Accessibility Menu
 

1 Wall Street Analyst Thinks Tilray Will Soar Nearly 75%. Is It a Buy Now?

International growth could make up for a lack of U.S. legalization progress

By Thomas Niel May 7, 2026 at 3:00PM EST

Key Points

  • Last month, Roth Capital's William Kirk upgraded Tilray Brands shares from "neutral" to "buy," raising his price target to $10 per share.
  • While investors may be focused largely on this cannabis company's U.S. legalization catalyst, Kirk cites other positive factors.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.